BRAF and melanoma: In the subgroup of patients whose melanomas do or do not harbor mutations in the BRAF gene, individuals with average 25(OH)D serum concentrations ≥10 ng/ml had over the complete OP a 72.5% (p = 0.63) and 85.2% (p = 0.000134), respectively, reduced risk to die, as compared to individuals with average 25(OH)D serum concentrations <10 ng/ml.